Anti-osteoporosis Medication Monitoring and Management Service

Osteoporosis Clinical Trial

Official title: Anti-osteoporosis Medication Monitoring and Management Service

Status Active, not recruiting

Clinical Trial Summary

BACKGROUND:

One-year adherence to oral anti-osteoporosis medication (AOMs) was only about 30%. In recent years, efforts have been made to change the delivery of these medications from oral form to injection form every, 3, 6 or 12 months to increase adherence. However, both patients and providers are sometimes confused about the multiple choices. Also, patients may receive extra medications if providers did not keep tract of their previous AOM uses or patients may changes providers. There were urgent needs to provide AOM monitoring and management services to improve cares.

OBJECTIVES:

To establish a anti-osteoporosis medication management service at National Taiwan University Hospital and its BeiHu Branch.

METHODS:

Participating physicians will select those eligible for services and refer to study coordinators. Study coordinators will conduct baseline assessments on osteoporosis/fracture risks, record medical conditions, AOMs, provide educations on osteoporosis, fracture, sarcopenia, fall, medications, nutrition, and exercise. They also arrange return clinic visit, telephone reminder and follow up for patients, and communicate with providers on regular bases. the investigators plan to enroll 500 patients with 18-month follow up for each.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Fracture
• Osteoporosis

• NCT number: NCT02194647
• Study type: Observational
• Source: National Taiwan University Hospital
• Status: Active, not recruiting
• Start date: July 2014
• Completion date: July 1, 2026